Clinical trials on coronavirus drugs may take only months, researcher says

Clinical trials on coronavirus drugs may take only months, researcher says

Researchers set up new labs to help fight coronavirus at the University of Minnesota
An infectious disease specialist leading three clinical trials into treatments for coronavirus said he expects the work to go quickly.
"If everything goes according to plan, I am talking months, not years," for completion of the trials, Dr. Timothy Schacker, vice dean for research at the University of Minnesota's medical school, told NBC News.
Clinical trials often can take years, Schacker said, but these may take less time in part because the process of finding patients to participate is happening quickly.
A high amount of interest in coronavirus treatment research is helping in recruiting participants, Schacker said. In addition, researchers are using the internet and social media to get the word out.
His teams' trials are trying to answer three questions, he said: Can you prevent a person from getting infected? Once a person has the coronavirus, can you prevent them from getting more sick? And, lastly, once a person is sick, is there a treatment to fight the infection?
To address the first question, the researchers are looking for people exposed to someone known to be infected and giving them hydroxychloroquine.
"We are giving the drug to see if we can prevent them from getting infected," he said.
Researchers at the school hope to enroll as many as 1,500 people who have had some contact with COVID-19 patients but who are not infected.
The trial will be randomized, meaning that some subjects will be given placebos, Schacker said.
Two other studies are also in the works. One will look at whether the blood-pressure drug Losartan "can slow progression in early patients who are not very sick," Schacker said.
A third clinical trial will look at the impact of remdesivir, a drug that was widely promoted for treating Ebola but which failed to show any significant benefit. It has shown some promise against COVID-19 in laboratory settings.
"It was put into this large clinical trial, so we have up and running as well," he said.

MMW

Comments

Post a Comment

Popular posts from this blog

That Uplifting Tweet You Just Shared? A Russian Troll Sent It

Image
Here’s what Russia’s 2020 disinformation operations look like, according to two experts on social media and propaganda. By   DARREN LINVILL   &   PATRICK WARREN Internet trolls don’t troll. Not the professionals at least. Professional trolls don’t go on social media to antagonize liberals or belittle conservatives. They are not narrow minded, drunk or angry. They don’t lack basic English language skills. They certainly aren’t  “somebody sitting on their bed that weighs 400 pounds,”  as the president once put it. Your stereotypical trolls do exist on social media, but the amateurs aren’t a threat to Western democracy. Professional trolls, on the other hand, are the tip of the spear in the new digital, ideological battleground. To combat the threat they pose, we must first understand them — and take them seriously. MORE: https://www.rollingstone.com/politics/politics-features/russia-troll-2020-election-interference-twitter-916482/ P...
Read more

The Nightmare Scenario That Keeps Election Lawyers Up At Night -- And Could Hand Trump A Second Term

Image
The Nightmare Scenario That Keeps Election Lawyers Up At Night -- And Could Hand Trump A Second Term   (Photo: Photos: Getty Images) Americans will almost certainly go to bed on Nov. 3 without knowing who won the presidential election. Since millions of people will vote by mail, constraints on time and resources will slow ballot counting into potentially a weeks-long process. Voting patterns suggest it’s likely that President  Donald Trump  could end Election Day in the lead in certain key states, only to be overtaken by Democratic opponent  Joe Biden  when more votes are tallied.  This could create a nightmare scenario during the three months stretching from Election Day to the Jan. 20 inauguration: a battle on the state and congressional level over who is the legitimate winner. This could include Congress reconvening on Jan. 6, presided over by Vice President  Mike Pence , with no consensus over its potential role in choosing the next president. This...
Read more

When Life Hands You Lemons

Image
 It's like this folks: sometimes your mind goes blank. Happens more than usual with me of course. Take this forum for instance. I wanted to post something today and couldn't think of a topic. At least not a non-sexual one and we know sexual ones lately have been frowned upon.  Then along comes one of our regulars and complains about something. Well, they might not say it was a complaint, just an observation, but it was a complaint. A minor one. It has something to do about being able to make something out of nothing. Sort of like me this morning, how to make a thread out of an empty head? But they (notice I am using the correct pronoun, not saying he or she), by what they said got me thinking. What I thought was: Not sure if that is the actual saying, if I remember correctly, I remember the saying going something like this: Umm, no, I don't think the saying I am thinking of goes that way either, maybe ONE of you good folks can remind me how the saying goes. Either way, when...
Read more